Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Josep M. Llovet, Roser Pinyol, Mark Yarchoan, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 294-311
Closed Access | Times Cited: 87

Showing 26-50 of 87 citing articles:

Irreversible electroporation combined with PD-L1/IL-6 dual blockade promotes anti-tumor immunity via cDC2/CD4+T cell axis in MHC-I deficient pancreatic cancer
Zhuozhuo Wu, Qungang Shan, Yuyue Jiang, et al.
Cancer Letters (2025), pp. 217620-217620
Closed Access
A Metrology Informatics Investigation of Conversion Therapy in Hepatocellular Carcinoma: 2014–2023
Qifeng Chen, Xiongying Jiang, Minshan Chen, et al.
Annals of Surgery Open (2025) Vol. 6, Iss. 1, pp. e562-e562
Open Access
Heparan sulfate chains in hepatocellular carcinoma
Erwan Guyot
Gastroenterology report (2025) Vol. 13
Open Access
Successful Liver Transplantation After Achieving Complete Clinical Remission of Hepatocellular Carcinoma With Combination Therapy of Immune Checkpoint Inhibitors and Targeted Agents: A Case Report
Shaobo Zhang, Shugeng Zhang
Transplantation Proceedings (2025)
Open Access
Deep learning based on intratumoral heterogeneity predicts histopathologic grade of hepatocellular carcinoma
Shaoming Song, Gong Zhang, Zhiyuan Yao, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Integrated analysis reveals an immune evasion prognostic signature for predicting the overall survival in patients with hepatocellular carcinoma
Jun Wen, Kai Wen, Tao Meng, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
The current status and future of targeted-immune combination for hepatocellular carcinoma
Liyuan Hao, Shenghao Li, Fanghang Ye, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment
Yanju Liu, Hongyuan Yang, Tian Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
N-linked glycosylation of PD-L1/PD-1: an emerging target for cancer diagnosis and treatment
Zhiyun Duan, Runhan Shi, Bo Gao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Multi-transcriptomics analysis of microvascular invasion-related malignant cells and development of a machine learning-based prognostic model in hepatocellular carcinoma
Haoran Huang, Feifeng Wu, Yang Yu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Two decades of advances in clinical oncology — lessons learned and future directions
Susana Banerjee, Christopher M. Booth, Éduardo Bruera, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 11, pp. 771-780
Closed Access | Times Cited: 3
Low-dose metformin suppresses hepatocellular carcinoma metastasis via the AMPK/JNK/IL-8 pathway
Chengwen Zhao, Lu Zheng, Yuting Ma, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access | Times Cited: 2
Plasma cell-free DNA methylomes for hepatocellular carcinoma detection and monitoring after liver resection or transplantation
K Chen, Zhihao Li, Bianca O. Kirsh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Perioperative Tislelizumab plus intensity modulated radiotherapy in resectable hepatocellular carcinoma with macrovascular invasion: a phase II trial
Hongyu Pan, Liuyu Zhou, Zhuo Cheng, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
LI-RADS Nonradiation Treatment Response Algorithm Version 2024: Diagnostic Performance and Impact of Ancillary Features
Shuwei Zhou, Guofeng Zhou, Yang Shen, et al.
American Journal of Roentgenology (2024)
Closed Access | Times Cited: 2
DNA methylation regulator-based molecular subtyping and tumor microenvironment characterization in hepatocellular carcinoma
Junsheng Zhao, Zhengtao Liu, Keda Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Macrophage hitchhiking for systematic suppression in postablative multifocal HCC
Xuehan Li, Yan Zhang, Shun Li, et al.
Hepatology (2024)
Closed Access | Times Cited: 1
Impact of neoadjuvant multimodal therapy in the setting of locally advanced hepatocellular carcinoma
Daniele Ferraro, Federica Falaschi, Luca Nazzaro, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 28, pp. 3452-3455
Open Access | Times Cited: 1
Decoding the Role of O-GlcNAcylation in Hepatocellular Carcinoma
Xinyu Zhou, Sirui Hang, Qingqing Wang, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 908-908
Open Access | Times Cited: 1
Impact of Neoadjuvant Immunotherapy on Recurrence-Free Survival in Patients with High-Risk Localized HCC
Mari Nakazawa, Mike Fang, Tyrus Vong, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 8, pp. 2123-2132
Open Access | Times Cited: 1
Development of Mutated β-catenin Gene Signature to identify CTNNB1 mutations from whole and spatial transcriptomic data in patients with HCC
Brandon M. Lehrich, Junyan Tao, Silvia Liu, et al.
JHEP Reports (2024) Vol. 6, Iss. 12, pp. 101186-101186
Open Access | Times Cited: 1
HMGB2 drives tumor progression and shapes the immunosuppressive microenvironment in hepatocellular carcinoma: insights from multi-omics analysis
Yanzhu Chen, Zhishang Meng, Zuo‐Lin Xiang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Role of UFMylation in tumorigenesis and cancer immunotherapy
Lijuan Ding, Xin Jiang, Te Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Baicalein Targets MAPK9 to Induce Apoptosis of Hepatocellular Carcinoma Cells
Weili Wang, Yuxiao Tang, Xiaobin Zhuo, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 3
Closed Access | Times Cited: 1
Nanomaterial-based cancer immunotherapy: enhancing treatment strategies
Mengxiang Tian, Xionglin Liu, Haiping Pei
Frontiers in Chemistry (2024) Vol. 12
Open Access | Times Cited: 1

Scroll to top